STANDARD CONTROL CHOICE FORMULARY

Serial Number 98002252
814

Registration Progress

Application Filed
May 18, 2023
Under Examination
Apr 30, 2024
Approved for Publication
Feb 14, 2024
Published for Opposition
Mar 5, 2024
Registered

Trademark Image

STANDARD CONTROL CHOICE FORMULARY

Basic Information

Serial Number
98002252
Filing Date
May 18, 2023
Published for Opposition
March 5, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
814
Status Date
Aug 7, 2025
Application
Pending
Classes
035 036

Rights Holder

CVS Pharmacy, Inc.

03
Address
One CVS Drive
Mailcode: 1160
Woonsocket, RI 02895

Ownership History

CVS Pharmacy, Inc.

Original Applicant
03
Woonsocket, RI

CVS Pharmacy, Inc.

Owner at Publication
03
Woonsocket, RI

Legal Representation

Attorney
Erich G. Rhynhart

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

23 events
Date Code Type Description Documents
Aug 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 7, 2025 ALIE A ASSIGNED TO LIE Loading...
Aug 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 31, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 17, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 17, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jul 17, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 17, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 17, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 30, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 5, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 5, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 14, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 29, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 22, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 22, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 22, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 22, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business administration of medical and pharmaceutical reimbursement collection for patients from private and public sources; Business administration of pharmaceutical reimbursement collection programs for others; Administration of employee pharmaceutical benefits, other than insurance benefits, concerning coordination of prescription pickups; Drug utilization review services and drug formulary management services; pharmaceutical cost management services
First Use Anywhere: Oct 1, 2023
First Use in Commerce: Oct 1, 2023
Class 036
Insurance and financial services pertaining to submission of medical claims, and handling of assignment of benefits, namely, medical insurance claims administrative services, financial administration of medical and pharmaceutical reimbursement collection for patients from private and public sources, financial administration of pharmaceutical reimbursement collection programs for others, administration of employee pharmaceutical benefits concerning insurance and finance, administration of prepaid employee health care plans, claims processing of pharmaceutical insurance benefits, namely, processing and administering individual prescription claims history, benefit amounts, accumulations for deductibles and out-of-pocket expenses and expense summaries; pharmacy benefit management services
First Use Anywhere: Oct 1, 2023
First Use in Commerce: Oct 1, 2023

Classification

International Classes
035 036

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FORMULARY"